Publicacións nas que colabora con Ángela Ibáñez Cuadrado (23)

2021

  1. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  2. The prevention of relapses in first episodes of schizophrenia: The 2EPs Project, background, rationale and study design

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 3, pp. 164-176

  3. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

  2. Influence of social cognition as a mediator between cognitive reserve and psychosocial functioning in patients with first episode psychosis

    Psychological Medicine, Vol. 50, Núm. 16, pp. 2702-2710

  3. Personalized medicine begins with the phenotype: identifying antipsychotic response phenotypes in a first-episode psychosis cohort

    Acta Psychiatrica Scandinavica, Vol. 141, Núm. 6, pp. 541-552

2019

  1. Pharmacological treatment of obsessive compulsive disorder in adults: A clinical practice guideline based on the ADAPTE methodology

    Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 2, pp. 77-91

  2. Tratamiento farmacológico del transtorno obsesivo compulsivo en adultos: guía de práctica clínica (basada en el método ADAPTE)

    Editorial Ediveramerica

2018

  1. Factors associated with poor functional outcome in bipolar disorder: sociodemographic, clinical, and neurocognitive variables

    Acta Psychiatrica Scandinavica, Vol. 138, Núm. 2, pp. 145-154

  2. Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

    Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256

  3. Smoking does not impact social and non-social cognition in patients with first episode psychosis

    Schizophrenia Research, Vol. 199, pp. 64-74

2017

  1. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

    European Neuropsychopharmacology, Vol. 27, Núm. 4, pp. 350-359

  2. Persistent negative symptoms in first-episode psychosis: Early cognitive and social functioning correlates and differences between early and adult onset

    Journal of Clinical Psychiatry, Vol. 78, Núm. 9, pp. 1414-1422

  3. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90

2016

  1. A Pharmacovigilance Study in First Episode of Psychosis: Psychopharmacological Interventions and Safety Profiles in the PEPs Project

    International Journal of Neuropsychopharmacology, Vol. 19, Núm. 4

  2. Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life

    Acta Psychiatrica Scandinavica, Vol. 133, Núm. 5, pp. 386-398

  3. Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory

    Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301

  4. Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome

    British Journal of Psychiatry, Vol. 208, Núm. 1, pp. 87-93

  5. Opposite cannabis-cognition associations in psychotic patients depending on family history

    PLoS ONE, Vol. 11, Núm. 8

2015

  1. Functional remediation for patients with bipolar II disorder: Improvement of functioning and subsyndromal symptoms

    European Neuropsychopharmacology, Vol. 25, Núm. 2, pp. 257-264